Ratings by William Blair (Steven Lichtman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/10/2026 | Cooper Companies | COO | Downgrade | Market Perform (Outperform) |
63.48 (57.94) |
-8.73% | Details | |
| 8/21/2026 | Beta Bionics, Inc. | BBNX | New Coverage | Market Perform (N/A) |
19.48 (16.35) |
-16.07% | Details | |
| 8/21/2026 | Tandem Diabetes Care | TNDM | New Coverage | Outperform (N/A) |
22.57 (16.24) |
-28.05% | Details | |
| 4/17/2026 | Enovis Corp | ENOV | New Coverage | Outperform (N/A) |
25.20 (19.59) |
-22.26% | Details | |
| 3/31/2026 | MiniMed Group | MMED | New Coverage | Outperform (N/A) |
14.35 (17.49) |
21.88% | Details | |
| 3/5/2026 | Sight Sciences Inc. | SGHT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2026 | Stryker | SYK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2026 | Zimmer Biomet | ZBH | New Coverage | Market Perform (N/A) |
99.25 (94.98) |
-4.3% | Details | |
| 2/20/2026 | Stryker | SYK | New Coverage | Outperform (N/A) |
372.66 (294.66) |
-20.93% | Details | |
| 1/30/2026 | Sight Sciences Inc. | SGHT | New Coverage | Outperform (N/A) |
6.15 (8.28) |
34.63% | Details | |
| 1/30/2026 | Cooper Companies | COO | New Coverage | Outperform (N/A) |
80.37 (63.48) |
-21.02% | Details | |
| 1/30/2026 | RxSight Inc. | RXST | New Coverage | Market Perform (N/A) |
8.91 (4.51) |
-49.38% | Details | |
| 1/30/2026 | Alcon Inc. | ALC | New Coverage | Market Perform (N/A) |
81.15 (66.18) |
-18.45% | Details |
